Neumora Therapeutics Inc.’s stock tumbled 80% Thursday, after the clinical-stage biotech said a late-stage trial of a ...

The National Institute of Mental Health defines depression, which is also known as clinical depression or major depressive ...

Unlike major depressive disorder, seasonal affective disorder usually lasts anywhere from a couple of weeks to a few months.

The best management of SAD involves strategies that attend to an individual’s mental, physical and emotional well-being,” New York psychologist Christopher Fisher told The Post.

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Navacaprant is an highly selective kappa opioid receptor antagonist expected to modulate reward processing pathways and mediate depressive states.

Older adults with major depressive disorder (MDD) demonstrate distinct and riskier driving behaviors than those without MDD, ...

Being proactive in your recovery doesn't mean blindly following what health professionals tell you. It means engaging in ...

Neumora Therapeutics (NMRA) crashed after its Phase 3 study for its lead asset navacaprant in major depressive disorder ...

Despite an understanding that major depressive disorder (MDD) has affected about 20% of adolescents aged 12 to 17, there is ...

In a statement, Neumora revealed that the KOASTAL-1 study missed its primary endpoint, with navacaprant failing to achieve a ...

Neumora's KOASTAL-1 study results show navacaprant missed key goals in major depressive disorder. Additional studies and ...